ReoPro

ReoPro

 
trademark for a preparation of abciximab, an antithrombotic agent.

ReoPro

(rē′ō-prō′)
A trademark for the drug abciximab.

ReoPro®

Abciximab, see there.

Reopro

A brand name for the drug ABCIXIMAB.
References in periodicals archive ?
Resume therapy the day after the procedure Glycoprotein IIb/IIIa Inhibitors * Abciximab (Reopro) Withhold 24 h.
Through strategic alliances, he and his teams also helped develop and support REOPRO (abciximab) with Centocor as well as Olumiant (baricitinib) with Incyte.
The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: The do Tirofiban and ReoPro give similar efficacy outcome (TARGET) trial.
In the TEG functional fibrinogen test, the tissue factor is used for coagulation activation described classically as extrinsic, with the platelet function inhibited by ReoPro (abciximab, Eli Lilly and Company, Indianapolis, Indiana), a GPIIb/IIIa inhibitor, so the resulting contribution of the functional fibrinogen to clot strength can be viewed.
beta (Cerezyme) ** Genzyme/Sanofi Platelet mAb Fab (Reopro) Janssen/J&J **Annual sales over $500 million Source: 11th Annual Report and Survey on Biomanufacturing Capacity and Production, April 2014 Overall, a total of 19 recombinant protein/mAb products (likely a few more as 2013 sales data become available) are known to be manufactured using perfusion.
2.--I am fairly comfortable with medications related to ischemic strokes (tpa, reopro, heparin, blood pressure medication, antilipids, blood glucose management, etc.) 3.--I know the difference between an ischemic stroke and a hemorrhagic stroke and how the treatment differs.
The hemiparesis was resolved by Reopro bolus and subsequent infusion.
Because of residual clot, the IIb/IIIa inhibitor, ReoPro, was given, and discontinued the same day.
VerifyNow is a rapid, simple, and accurate system for measuring individual response to every major antiplatelet medication, including aspirin, Plavix, ReoPro, and Integrilin.
Different GPIIb/IIIa inhibitors--abciximab (ReoPro), eptifibatide (Integrilin), and tirofiban (Aggrastat)--are given intravenously before angioplasty or during a suspected heart attack.
The guidelines also call for treatment with a glycoprotein IIb/IIIa inhibitor, such as eptifibatide (Integrilin), tirofiban (Aggrastat), or abciximab (ReoPro) for recurrent angina or prior to diagnostic angiography or coronary stenting.
* Eli Lilly and Co.'s major products include Prozac (an antidepressant), Axid (antiulcer), Kefzol, Ceclor, Lorabid (antibiotics), Zyprexa (schizophrenia), Humatrope (human growth hormone), Humulin (insulin), Reopro (angioplasty) and Evista (osteoporosis).